Johnson & Johnson

1. 01

   2.0% below its 52-week high

   Closed at $276.32 on 4 Nov 2026: 2.0% below the 52-week high of $282.02 (30 Oct 2026) and 49.3% above the low of $185.12 (10 Nov 2025).

   Daily price bars, split-adjusted · as of 4 Nov 2026

2. 02

   Ahead of SPY and its sector fund XLV over 1 year

   1 month: +8.5% (SPY −1.6%, XLV +13.5%). 3 months: +7.3% (SPY −0.4%, XLV +15.5%). 1 year: +47.9% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: JNJ, SPY and XLV · as of 4 Nov 2026

3. 03

   Rose 3.8% on 4 Nov 2026

   The 4 Nov 2026 gain of 3.8% was 3.8× its average daily move of 1.0% over the past year, and its largest one-day gain since 26 Jun 2026.

   Daily closes, split-adjusted · as of 4 Nov 2026

4. 04

   Above its 50- and 200-day averages

   The 4 Nov 2026 close of $276.32 was 4.1% above its 50-day average ($265.53) and 11.5% above its 200-day average ($247.77). It has closed above the 200-day for 330 sessions, since 16 Jul 2025. The 50-day average crossed above the 200-day on 24 Jul 2025, 323 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

5. 05

   P/E 12.1% below its peers' median

   Trailing P/E of 42.6 against a median of 48.4 across 4 peers named in its company record (range 44.0 to 120.3).

   Quote feed P/E (price ÷ trailing 12-month EPS); peers as named in the company record · as of 5 Nov 2026

At the 4 Nov 2026 close